Yinan Liu

The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients

Shang‐Gin Wu, Yinan Liu, Meng‐Feng Tsai et al. · Oncotarget · 2016 · 236 citations · Full text

Medicine, Oncology, Pharmacology +17

Osimertinib as neoadjuvant therapy in patients with EGFR-mutant resectable stage II-IIIB lung adenocarcinoma (NEOS): A multicenter, single-arm, open-label phase 2b trial

Chao Lv, Wentao Fang, Nan Wu et al. · Lung Cancer · 2023 · 110 citations · Full text

Medicine, Oncology, Pharmacology +17

IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer

Yinan Liu, Tzu‐Hua Chang, Meng‐Feng Tsai et al. · Oncotarget · 2015 · 88 citations · Full text

Medicine, Oncology, Pharmacology +17

Expression of inflammatory cytokines in serum and peritoneal fluid from patients with different stages of endometriosis

Yanyan Fan, Hongyu Chen, Wei Chen et al. · Gynecological Endocrinology · 2018 · 87 citations

Medicine, Gynecology, Immunology +14

Clinical and the Prognostic Characteristics of Lung Adenocarcinoma Patients with ROS1 Fusion in Comparison with Other Driver Mutations in East Asian Populations

Yen‐Fu Chen, Min‐Shu Hsieh, Shang‐Gin Wu et al. · Journal of Thoracic Oncology · 2014 · 82 citations

Medicine, Genetics, Oncology +17